These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 17317613)

  • 21. Systemic sclerosis (scleroderma): specific autoantigen genes are selectively overexpressed in scleroderma fibroblasts.
    Zhou X; Tan FK; Xiong M; Milewicz DM; Feghali CA; Fritzler MJ; Reveille JD; Arnett FC
    J Immunol; 2001 Dec; 167(12):7126-33. PubMed ID: 11739535
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DNA topoisomerase I binding to fibroblasts induces monocyte adhesion and activation in the presence of anti-topoisomerase I autoantibodies from systemic sclerosis patients.
    Hénault J; Robitaille G; Senécal JL; Raymond Y
    Arthritis Rheum; 2006 Mar; 54(3):963-73. PubMed ID: 16508979
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antifibroblast antibodies from systemic sclerosis patients are internalized by fibroblasts via a caveolin-linked pathway.
    Ronda N; Gatti R; Giacosa R; Raschi E; Testoni C; Meroni PL; Buzio C; Orlandini G
    Arthritis Rheum; 2002 Jun; 46(6):1595-601. PubMed ID: 12115191
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-p53 autoantibody in systemic sclerosis: association with limited cutaneous systemic sclerosis.
    Hara T; Ogawa F; Muroi E; Komura K; Takenaka M; Hasegawa M; Fujimoto M; Sato S
    J Rheumatol; 2008 Mar; 35(3):451-7. PubMed ID: 18203319
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autoantibody reactive with three classes of RNA polymerases in sera from patients with systemic sclerosis.
    Kuwana M; Kaburaki J; Mimori T; Tojo T; Homma M
    J Clin Invest; 1993 Apr; 91(4):1399-404. PubMed ID: 8473491
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of osteonectin and matrix Gla protein in scleroderma patients with and without calcinosis.
    Davies CA; Jeziorska M; Freemont AJ; Herrick AL
    Rheumatology (Oxford); 2006 Nov; 45(11):1349-55. PubMed ID: 17050587
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Naturally occurring and disease-associated auto-antibodies against topoisomerase I: a fine epitope mapping study in systemic sclerosis and systemic lupus erythematosus.
    Simon D; Czömpöly T; Berki T; Minier T; Peti A; Tóth E; Czirják L; Németh P
    Int Immunol; 2009 Apr; 21(4):415-22. PubMed ID: 19211583
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human scleroderma sera contain autoantibodies to protein components specific to the U3 small nucleolar RNP complex.
    Yang JM; Hildebrandt B; Luderschmidt C; Pollard KM
    Arthritis Rheum; 2003 Jan; 48(1):210-7. PubMed ID: 12528121
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis.
    Koenig M; Joyal F; Fritzler MJ; Roussin A; Abrahamowicz M; Boire G; Goulet JR; Rich E; Grodzicky T; Raymond Y; Senécal JL
    Arthritis Rheum; 2008 Dec; 58(12):3902-12. PubMed ID: 19035499
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-endothelial cell antibodies in systemic sclerosis.
    Mihai C; Tervaert JW
    Ann Rheum Dis; 2010 Feb; 69(2):319-24. PubMed ID: 20107031
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased serum pentraxin 3 in patients with systemic sclerosis.
    Iwata Y; Yoshizaki A; Ogawa F; Komura K; Hara T; Muroi E; Takenaka M; Shimizu K; Hasegawa M; Fujimoto M; Takehara K; Sato S
    J Rheumatol; 2009 May; 36(5):976-83. PubMed ID: 19273457
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monocyte chemoattractant proteins in the pathogenesis of systemic sclerosis.
    Distler JH; Akhmetshina A; Schett G; Distler O
    Rheumatology (Oxford); 2009 Feb; 48(2):98-103. PubMed ID: 18984611
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autoantibodies to a collagen-specific molecular chaperone, heat-shock protein 47, in systemic sclerosis.
    Fujimoto M; Hamaguchi Y; Yazawa N; Komura K; Takehara K; Sato S
    Clin Exp Immunol; 2004 Dec; 138(3):534-9. PubMed ID: 15544633
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-fibroblast antibodies detected by cell-based ELISA in systemic sclerosis enhance the collagenolytic activity and matrix metalloproteinase-1 production in dermal fibroblasts.
    Fineschi S; Cozzi F; Burger D; Dayer JM; Meroni PL; Chizzolini C
    Rheumatology (Oxford); 2007 Dec; 46(12):1779-85. PubMed ID: 17982166
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serologic abnormalities in systemic sclerosis.
    Harvey GR; McHugh NJ
    Curr Opin Rheumatol; 1999 Nov; 11(6):495-502. PubMed ID: 10551674
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selective oxidation of DNA topoisomerase 1 induces systemic sclerosis in the mouse.
    Servettaz A; Goulvestre C; Kavian N; Nicco C; Guilpain P; Chéreau C; Vuiblet V; Guillevin L; Mouthon L; Weill B; Batteux F
    J Immunol; 2009 May; 182(9):5855-64. PubMed ID: 19380834
    [TBL] [Abstract][Full Text] [Related]  

  • 37. C1D is a major autoantibody target in patients with the polymyositis-scleroderma overlap syndrome.
    Schilders G; Egberts WV; Raijmakers R; Pruijn GJ
    Arthritis Rheum; 2007 Jul; 56(7):2449-54. PubMed ID: 17599775
    [TBL] [Abstract][Full Text] [Related]  

  • 38. EM703, the new derivative of erythromycin, inhibits transcription of type I collagen in normal and scleroderma fibroblasts.
    Ikeda H; Sunazuka T; Suzuki H; Hamasaki Y; Yamazaki S; Omura S; Hatamochi A
    J Dermatol Sci; 2008 Mar; 49(3):195-205. PubMed ID: 18036782
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recognition of Granzyme B-generated autoantigen fragments in scleroderma patients with ischemic digital loss.
    Schachna L; Wigley FM; Morris S; Gelber AC; Rosen A; Casciola-Rosen L
    Arthritis Rheum; 2002 Jul; 46(7):1873-84. PubMed ID: 12124872
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recruitment of topoisomerase I (Scl-70) to nucleoplasmic proteasomes in response to xenobiotics suggests a role for altered antigen processing in scleroderma.
    Chen M; Dittmann A; Kuhn A; Ruzicka T; von Mikecz A
    Arthritis Rheum; 2005 Mar; 52(3):877-84. PubMed ID: 15751092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.